Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
BCAX holding history
Bicara Therapeutics Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCAX overviewAll 13F holders of BCAXFull Q2 2026 holdings
- Shares (Q2 2026)
- 211,142
- Value
- $6.27M
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 211,142 | $6.27M | <0.1% | −1,448,200−87.3% | Reduced | Holders |
| Q1 2026 | 1,659,342 | $33.0M | <0.1% | +887,084+114.9% | Added | Holders |
| Q4 2025 | 772,258 | $13.0M | <0.1% | +772,258 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −221,516−100.0% | Sold out | Holders |
| Q2 2025 | 221,516 | $2.06M | <0.1% | +221,516 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −234,122−100.0% | Sold out | Holders |
| Q3 2024 | 234,122 | $5.96M | <0.1% | +234,122 | New | Holders |